ADCT-402 - a drug to watch
COMy 2016: Highlights from Day 1
Arnon Nagler et al.
A Pharmacist's view on biosimilars
Vadastuximab talirine: mechanism of action and combination with hypomethylating agents
Results of Phase Ib/II study of ricolinostat in multiple myeloma